Pipecolic Acid, a Putative Mediator of the Encephalopathy of Cerebral Malaria and the Experimental Model of Cerebral Malaria.
Pipecolic Acid, a Putative Mediator of the Encephalopathy of Cerebral Malaria and the Experimental Model of Cerebral Malaria.
复制标题
哌可酸,脑型疟疾脑病和脑型疟疾实验模型的假定介质。
DOI:
10.1093/infdis/jiab615
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Daily,JohannaP
中科院分区:
文献类型:
--
作者:
Keswani,Tarun;Obeidallah,Aisha;Nieves,Edward;Sidoli,Simone;Fazzari,Melissa;Taylor,Terrie;Seydel,Karl;Daily,JohannaP
BackgroundWe explored a metabolic etiology of cerebral malaria (CM) coma.MethodsPlasma metabolites were compared between Malawian children with CM and mildPlasmodium falciparummalaria. A candidate molecule was further studied in animal models of malaria.ResultsClinically abnormal concentrations of pipecolic acid (PA) were present in CM plasma, and nearly normal in mild malaria samples. PA is renally cleared and the elevated PA blood levels were associated with renal insufficiency, which was present only in CM subjects. Prior studies demonstrate that PA has neuromodulatory effects and is generated by malaria parasites. PA brain levels inPlasmodium bergheiANKA–infected animals in the experimental cerebral malaria (ECM) model inversely correlated with normal behavior and correlated with blood-brain barrier (BBB) permeability. Mice infected with malaria species that do not induce neurological abnormalities or manifest BBB permeability had elevated plasma PA levels similar to ECM plasma at 7 days postinfection; however, they had low PA levels in the brain compared to ECM mice brains at 7 days postinfection.ConclusionsOur model suggests that malaria-generated PA induces coma in CM and in ECM. The role of BBB permeability and the mechanisms of PA neuromodulation in CM will require additional investigation.